on the role of miRNAs in VTCs, revealing their potential as therapeutic targets and
diagnostic and prognostic
Дьяконов, В.А.,
Джемилева, Л.У.,
Джемилев, У.М.,
D'yakonov, V.A.,
Dzhemileva, L.U.,
Dzhemilev, U.M. (2017) of altering catalytic activity of ferment by stabilizing the covalent
DNA-protein complexes.
The present
spine. 1324 deoxyribonucleic acid (
DNA) samples were genotyped using a fluorescent endpoint genotyping
GILYAZOVA, I.R.,
KLIMENTOVA, E.A.,
BERMISHEVA, M.A.,
KHUSNUTDINOVA, E.K.,
IZMAILOV, A.A.,
GALIMOVA, E.F.,
SAFIULLIN, R.I.,
GALIMOV, S.N.,
V.N. Pavlov,
BULYGIN, K.V. (2020) was performed on 23 paired
DNA samples extracted from kidney tumour tissue and the surrounding normal renal
Макара, Н.С.,
Вахитова, Ю.В.,
Зарудий, Ф.С.,
Tsypysheva, I.P.,
Kovalskaya, A.V.,
Lobov, A.N.,
Petrova, P.R.,
Farafontova, E.I.,
Zainullina, L.F.,
Makara N.S.,
Vakhitova, Yu.V.,
Zarudii, F.S. (2015) DNA-binding activity). The cytotoxicity of the synthesized compounds was assessed. The lead compound
Baltina, L.A.,
Stolyarova, O.V.,
Kondratenko, R.M.,
Gabbasov, T.M.,
Baltina, L.A.,
Plyasunova, O.A.,
Il’ina, T.V. (2014) accumulation of virus-specific protein p24 and RNA-dependent
DNA-polymerase activity of HIV-1 reverse